Skip to main content
. 2023 Oct 16;16(10):100823. doi: 10.1016/j.waojou.2023.100823

Table 1.

Demographic and lifestyle characteristics by investigator-classified asthma severity and practice type.

Demographic and lifestyle characteristics All (N = 3066)a Primary care (n = 559)
Specialists (n = 2498)
Investigator-classified mild asthma (n = 260) Investigator-classified moderate-to-severe asthma (n = 299) All (n = 559) Investigator-classified mild asthma (n = 289) Investigator-classified moderate-to-severe asthma (n = 2209) All (n = 2498)
Age (years)
Mean (SD) 51.8 (16.7) 46.2 (16.8) 50.1 (16.3) 48.3 (16.6) 45.5 (19.9) 53.5 (15.9) 52.6 (16.6)
Range 12.0–92.0 12.0–81.0 15.0–91.0 12.0–91.0 12.0–88.0 12.0–92.0 12.0–92.0
Age groups (years)
12–17 87 (2.8) 24 (9.2) 3 (1.0) 27 (4.8) 40 (13.8) 20 (0.9) 60 (2.4)
18–54 1515 (49.4) 137 (52.7) 180 (60.2) 317 (56.7) 141 (48.8) 1052 (47.6) 1193 (47.8)
≥55 1464 (47.7) 99 (38.1) 116 (38.8) 215 (38.5) 108 (37.4) 1137 (51.5) 1245 (49.8)
Sex
Female 2116 (69.0) 191 (73.5) 211 (70.6) 402 (71.9) 191 (66.1) 1516 (68.6) 1707 (68.3)
Male 950 (31.0) 69 (26.5) 88 (29.4) 157 (28.1) 98 (33.9) 693 (31.4) 791 (31.7)
BMI (kg/m2)
Mean (SD) 26.3 (5.6) 27.2 (6.0) 26.5 (6.1) 26.8 (6.1) 25.6 (5.7) 26.3 (5.4) 26.2 (5.5)
Median (min, max) 25.5 (12.6, 71.3) 26.5 (12.6, 49.7) 25.4 (16.6, 52.5) 25.8 (12.6, 52.5) 25.0 (14.9, 58.7) 25.5 (14.2, 71.3) 25.5 (14.2, 71.3)
BMI groupsb(kg/m2)
<18.5 127 (4.1) NA NA NA NA NA NA
18.5–22.9 716 (23.4) NA NA NA NA NA NA
23–24.9 521 (17.0) NA NA NA NA NA NA
≥25 1702 (55.5) NA NA NA NA NA NA
Education level
Not established 302 (9.8) 8 (3.1) 28 (9.4) 36 (6.4) 19 (6.6) 245 (11.1) 264 (10.6)
Primary or secondary school 1162 (37.9) 149 (57.3) 116 (38.8) 265 (47.4) 96 (33.2) 798 (36.1) 894 (35.8)
High school 675 (22.0) 51 (19.6) 51 (17.1) 102 (18.2) 90 (31.1) 481 (21.8) 571 (22.9)
University and/or post-graduate education 927 (30.2) 52 (20.0) 104 (34.8) 156 (27.9) 84 (29.1) 685 (31.0) 769 (30.8)
Healthcare insurance/medication funding
Not reimbursed 655 (21.4) 42 (16.2) 53 (17.7) 95 (17.0) 78 (27.0) 481 (21.8) 559 (22.4)
Partially reimbursed 775 (25.3) 17 (6.5) 107 (35.8) 124 (22.2) 78 (27.0) 568 (25.7) 646 (25.9)
Fully reimbursed 1469 (47.9) 194 (74.6) 118 (39.5) 312 (55.8) 127 (43.9) 1027 (46.5) 1154 (46.2)
Unknown 167 (5.4) 8 (3.1) 28 (9.4) 36 (6.4) 19 (6.6) 245 (11.1) 264 (10.6)
Smoking status
Active smoker 126 (4.1) 11 (4.2) 20 (6.7) 31 (5.5) 7 (2.4) 88 (4.0) 95 (3.8)
Former smoker 349 (11.4) 23 (8.8) 36 (12.0) 59 (10.6) 25 (8.7) 265 (12.0) 290 (11.6)
Never smoker 2591 (84.5) 226 (86.9) 243 (81.3) 469 (83.9) 257 (88.9) 1856 (84.0) 2113 (84.6)
Number of comorbidities
0 981 (32.0) 94 (36.2) 112 (37.5) 206 (36.9) 103 (35.6) 670 (30.3) 773 (30.9)
1–2 1508 (49.2) 126 (48.5) 111 (37.1) 237 (42.4) 147 (50.9) 1118 (50.6) 1265 (50.6)
3–4 455 (14.8) 39 (15.0) 60 (20.1) 99 (17.7) 33 (11.4) 323 (14.6) 356 (14.3)
≥5 122 (4.0) 1 (0.4) 16 (5.4) 17 (3.0) 6 (2.1) 98 (4.4) 104 (4.2)

BMI, body mass index; max, maximum; min, minimum; NA, not available; SD, standard deviation, WHO, World Health Organization. Data are presented as n (%) unless otherwise specified.

a

Practice type was not recorded for 9 patients.

b

According to Asia-Pacific BMI classification. The Asia-Pacific BMI classification data were available for the broad BMI categories; however, the stratification by practice type was only available as per the WHO classification. Therefore, all fields under practice type are marked as NA